. Author manuscript; available in PMC: 2016 Jun 17.

Published in final edited form as: Bone Marrow Transplant. 2012 May 14;47(12):1513–1519. doi: 10.1038/bmt.2012.81

Table 3. Table listing causes of death in patients in each group.

Cause of death	No ATG	ATG total	ATG 10 mg/kg cohort
Number deceased	18	25	18
Relapse	6	10	5
aGVHD	7	4	3
cGVHD	2	0	0
Infection	1^a	7^a	6
Other	2	4	4

Other: no ATG—lung cancer; pulmonary edema. ATG—post-transplant lymphoproliferative disorder/pulmonary edema; alveolar hemorrhage²; thrombotic thrombocytopenic purpura.

Infection: no ATG—vancomycin-resistant Enterococcal (VRE) sepsis. ATG—VRE sepsis; disseminated toxoplasmosis (brain, heart lung); pulmonary Rhizopus and Zygomycetes; Mycobacterium avium bacteremia; Influenza A: pulmonary Aspergillosis: Pseudomonas aeruginosa encephalitis wound infection.